Sequence constancies and variations in genes encoding three new meningococcal vaccine candidate antigens

被引:48
作者
Jacobsson, S [1 ]
Thulin, S
Mölling, P
Unemo, M
Comanducci, M
Rappuoli, R
Olcén, P
机构
[1] Orebro Univ Hosp, Dept Clin Microbiol, Natl Ref Lab Pathogen Neisseria, Orebro, Sweden
[2] IRIS, Siena, Italy
关键词
Neisseria meningitidis; vaccine; genome-derived neisserial antigen (GNA);
D O I
10.1016/j.vaccine.2005.11.006
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
By the strategy "reverse vaccinology" a number of new antigens have been identified in Neisseria meningitidis, which are potential candidates for a highly needed broad-spectrum meningococcal vaccine. In the present study we examined the prevalence, sequence constancies and variations of the genes encoding three of these new antigens designated, genome-derived neisserial antigen (GNA) 1870, GNA1946 and GNA2132. All three genes were present in all N. meningitidis isolates tested. Concerning gna1870, three major variants of the gene sequences and deduced amino acid sequences were identified and 56% of the deduced amino acids were conserved in all isolates. In gna1946, 98% of the deduced amino acids were conserved and in gna2132, 54% of the deduced amino acids were conserved. Based on gene prevalence and conservation, all three antigens are promising candidates for an effective meningococcal vaccine against all N. meningitidis irrespective of serogroup. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:2161 / 2168
页数:8
相关论文
共 26 条
[1]   EFFECT OF OUTER-MEMBRANE VESICLE VACCINE AGAINST GROUP-B MENINGOCOCCAL DISEASE IN NORWAY [J].
BJUNE, G ;
HOIBY, EA ;
GRONNESBY, JK ;
ARNESEN, O ;
HOLSTFREDRIKSEN, J ;
HALSTENSEN, A ;
HOLTEN, E ;
LINDBAK, AK ;
NOKLEBY, H ;
ROSENQVIST, E ;
SOLBERG, LK ;
CLOSS, O ;
ENG, J ;
FROHOLM, LO ;
LYSTAD, A ;
BAKKETEIG, LS ;
HAREIDE, B .
LANCET, 1991, 338 (8775) :1093-1096
[2]  
FINNE J, 1983, LANCET, V2, P355
[3]  
FINNE J, 1987, J IMMUNOL, V138, P4402
[4]  
Frasch CE, 1995, MENINGOCOCCAL DIS, P245
[5]   The region comprising amino acids 100 to 255 of Neisseria meningitidis, lipoprotein GNA 1870 elicits bactericidal antibodies [J].
Giuliani, MM ;
Santini, L ;
Brunelli, B ;
Biolchi, A ;
Aricò, B ;
Di Marcello, F ;
Cartocci, E ;
Comanducci, M ;
Masignani, V ;
Lozzi, L ;
Savino, S ;
Scarselli, M ;
Rappuoli, R ;
Pizza, M .
INFECTION AND IMMUNITY, 2005, 73 (02) :1151-1160
[6]   Molecular characterisation of group A Neisseria meningithdis isolated in Sudan 1985-2001 [J].
Jacobsson, S ;
Issa, M ;
Unemo, M ;
Bäckman, A ;
Mölling, P ;
Sulaiman, N ;
Olcén, P .
APMIS, 2003, 111 (11) :1060-1066
[7]   MEGA2: molecular evolutionary genetics analysis software [J].
Kumar, S ;
Tamura, K ;
Jakobsen, IB ;
Nei, M .
BIOINFORMATICS, 2001, 17 (12) :1244-1245
[8]   Vaccination against Neisseria meningitidis using three variants of the lipoprotein GNA1870 [J].
Masignani, V ;
Comanducci, M ;
Giuliani, MM ;
Bambini, S ;
Adu-Bobie, J ;
Aricò, B ;
Brunelli, B ;
Pieri, A ;
Santini, L ;
Savino, S ;
Serruto, D ;
Litt, D ;
Kroll, S ;
Welsch, JA ;
Granoff, DM ;
Rappuoli, R ;
Pizza, M .
JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 197 (06) :789-799
[9]  
NEI M, 1986, MOL BIOL EVOL, V3, P418
[10]   ASSESSMENT OF THE DIRECT EFFECTIVENESS OF BC MENINGOCOCCAL VACCINE IN RIO-DE-JANEIRO, BRAZIL - A CASE-CONTROL STUDY [J].
NORONHA, CP ;
STRUCHINER, CJ ;
HALLORAN, ME .
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 1995, 24 (05) :1050-1057